Comparative effectiveness of ozanimod versus dimethyl fumarate: results of a matching-adjusted indirect comparison

被引:0
|
作者
Cohan, S. [1 ]
Kumar, J. [2 ]
Arndorfer, S. [3 ]
Zhu, X. [3 ]
Zivkovic, M. [3 ]
Tencer, T. [2 ]
机构
[1] Providence Multiple Sclerosis Ctr, Portland, OR USA
[2] Bristol Myers Squibb, Princeton, NJ USA
[3] Genesis Res, Hoboken, NJ USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P0046
引用
收藏
页码:140 / 140
页数:1
相关论文
共 50 条
  • [1] Comparative effectiveness of delayed-release dimethyl fumarate versus glatiramer acetate in multiple sclerosis patients: results of a matching-adjusted indirect comparison
    Chan, Andrew
    Cutter, Gary
    Fox, Robert J.
    Xiao, James
    Lewin, James B.
    Edwards, Michael R.
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2017, 6 (04) : 313 - 323
  • [2] Comparative Efficacy and Safety of Ozanimod and Dimethyl Fumarate for Relapsing-Remitting Multiple Sclerosis Using Matching-Adjusted Indirect Comparison
    Cohan, Stanley
    Kumar, Jinender
    Arndorfer, Stella
    Zhu, Xuelian
    Zivkovic, Marko
    Tencer, Tom
    CNS DRUGS, 2021, 35 (07) : 795 - 804
  • [3] Comparative Efficacy and Safety of Ozanimod and Dimethyl Fumarate for Relapsing-Remitting Multiple Sclerosis Using Matching-Adjusted Indirect Comparison
    Stanley Cohan
    Jinender Kumar
    Stella Arndorfer
    Xuelian Zhu
    Marko Zivkovic
    Tom Tencer
    CNS Drugs, 2021, 35 : 795 - 804
  • [4] Matching-adjusted indirect treatment comparison of ozanimod versus teriflunomide for relapsing multiple sclerosis
    Cohan, Stanley
    Tencer, Tom
    Arndorfer, Stella
    Zhu, Xuelian
    Zivkovic, Marko
    Kumar, Jinender
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 52
  • [5] SECUKINUMAB FOR THE TREATMENT OF ANKYLOSING SPONDYLITIS: COMPARATIVE EFFECTIVENESS RESULTS VERSUS ADALIMUMAB USING A MATCHING-ADJUSTED INDIRECT COMPARISON
    Maksymowych, W.
    Strand, V
    Baeten, D.
    Nash, P.
    Thom, H.
    Hunger, M.
    Gandhi, K.
    Richards, H.
    Jugl, S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (04) : 782 - 782
  • [6] SECUKINUMAB FOR THE TREATMENT OF ANKYLOSING SPONDYLITIS: COMPARATIVE EFFECTIVENESS RESULTS VERSUS ADALIMUMAB USING A MATCHING-ADJUSTED INDIRECT COMPARISON
    Maksymowych, W.
    Strand, V.
    Baeten, D.
    Nash, P.
    Thom, H.
    Cure, S.
    Palaka, E.
    Gandhi, K.
    Richards, H.
    Jugl, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 98 - 98
  • [7] Comparative effectiveness using a matching-adjusted indirect comparison between delayed-release dimethyl fumarate and fingolimod for the treatment of multiple sclerosis
    Fox, Robert J.
    Chan, Andrew
    Zhang, Annie
    Xiao, James
    Levison, Dane
    Lewin, James B.
    Edwards, Michael R.
    Marantz, Jing L.
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (02) : 175 - 183
  • [8] Comparative efficacy and safety of ozanimod and ponesimod for relapsing multiple sclerosis: A matching-adjusted indirect comparison
    Swallow, Elyse
    Pham, Timothy
    Patterson-Lomba, Oscar
    Yin, Lei
    Gomez-Lievano, Andres
    Liu, Jingyi
    Tencer, Tom
    Gupte-Singh, Komal
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 71
  • [9] Comparative efficacy and safety of ozanimod versus teriflunomide for relapsing-remitting multiple sclerosis: a matching-adjusted indirect comparison
    Cohan, S.
    Kumar, J.
    Arndorfer, S.
    Zhu, X.
    Zivkovic, M.
    Tencer, T.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 140 - 140
  • [10] Comparative effectiveness of erenumab versus rimegepant for migraine prevention using matching-adjusted indirect comparison
    Mahon, Ronan
    Tiwari, Santosh
    Koch, Mirja
    Ferraris, Matias
    Betts, Keith A.
    Wang, Yan
    Gao, Sophie
    Proot, Pascal
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2024, 13 (03)